MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Arcutis Biotherapeutics Inc

Închisă

SectorSănătate

14.61 -0.48

Rezumat

Modificarea prețului

24h

Curent

Minim

14.49

Maxim

14.7

Indicatori cheie

By Trading Economics

Venit

31M

-11M

Vânzări

27M

71M

EPS

-0.09

Marjă de profit

-15.118

Angajați

342

EBITDA

29M

-4.5M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+29.08% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

155M

1.6B

Deschiderea anterioară

15.09

Închiderea anterioară

14.61

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

Arcutis Biotherapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 apr. 2025, 17:01 UTC

Câștiguri
Principalele dinamici ale pieței

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25 apr. 2025, 16:10 UTC

Câștiguri
Principalele dinamici ale pieței

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26 apr. 2025, 18:14 UTC

Câștiguri

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26 apr. 2025, 15:00 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26 apr. 2025, 08:20 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

25 apr. 2025, 21:24 UTC

Top știri

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25 apr. 2025, 20:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

25 apr. 2025, 20:45 UTC

Top știri

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25 apr. 2025, 20:39 UTC

Câștiguri

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25 apr. 2025, 20:37 UTC

Top știri

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25 apr. 2025, 20:19 UTC

Top știri

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25 apr. 2025, 20:15 UTC

Câștiguri

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25 apr. 2025, 19:23 UTC

Market Talk

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25 apr. 2025, 19:18 UTC

Market Talk

Oil Futures End Choppy Week With Losses -- Market Talk

25 apr. 2025, 18:47 UTC

Market Talk

Gold Extends Pullback to Close Week -- Market Talk

25 apr. 2025, 18:39 UTC

Top știri

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25 apr. 2025, 18:34 UTC

Achiziții, Fuziuni, Preluări

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25 apr. 2025, 18:32 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

25 apr. 2025, 18:32 UTC

Market Talk
Câștiguri

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25 apr. 2025, 18:08 UTC

Câștiguri

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25 apr. 2025, 17:55 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25 apr. 2025, 17:40 UTC

Top știri

Consumers Continue to Sour on the Economy -- 4th Update

25 apr. 2025, 17:38 UTC

Câștiguri

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25 apr. 2025, 17:07 UTC

Market Talk

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25 apr. 2025, 16:54 UTC

Market Talk
Câștiguri

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25 apr. 2025, 16:46 UTC

Câștiguri

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25 apr. 2025, 16:20 UTC

Market Talk
Câștiguri

Basic Materials Roundup: Market Talk

25 apr. 2025, 16:12 UTC

Top știri

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

25 apr. 2025, 16:03 UTC

Câștiguri

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

25 apr. 2025, 15:52 UTC

Market Talk

Grains Mixed on Low Volume Trade -- Market Talk

Comparație

Modificare preț

Arcutis Biotherapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

29.08% sus

Prognoză pe 12 luni

Medie 19 USD  29.08%

Maxim 21 USD

Minim 15 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruArcutis Biotherapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

7

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

14.01 / 14.72Suport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.